Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Yes, Cymbalta (duloxetine) can cause low blood sodium, usually through SIADH, and older women are one of the highest-risk groups. Risk rises with age over 65, low body weight, diuretic or other antidepressant use, dehydration, and the first two to four weeks after starting or increasing the dose. Warning signs can be subtle and easy to blame on aging, including headache, confusion, memory changes, weakness, unsteadiness, nausea, and falls, while severe drops in sodium can lead to seizures. There are several important factors, timelines, and symptom patterns to consider, so review the complete details below rather than the short summary alone.
Because confusion, fatigue, and dizziness in an older adult can point to hyponatremia, a medication effect, or something entirely different, it is worth taking a free, instant, online symptom check to organize your symptoms, understand how urgent they may be, and know what to ask your prescriber before your next dose.
Last reviewed for medical accuracy: 09/13/2025
Does Cymbalta Cause Low Sodium in Older Women?
Cymbalta (duloxetine) is a commonly prescribed antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) class. It’s approved for major depressive disorder, generalized anxiety disorder, and certain pain conditions. While Cymbalta can be effective, it carries potential side effects—including a rare but important risk of low sodium (hyponatremia), especially among older women. This article breaks down what the research and clinical experience tell us, how to recognize warning signs, and when to seek help.
Antidepressants like Cymbalta can sometimes trigger a condition called the syndrome of inappropriate antidiuretic hormone secretion (SIADH). In SIADH, your body retains too much water, which dilutes the sodium in your bloodstream. Sodium is vital for nerve and muscle function, and when levels drop, you may experience symptoms ranging from mild to severe.
Key mechanisms:
Several factors contribute to a greater risk of low sodium in older women taking Cymbalta:
True rates of Cymbalta-induced hyponatremia are low, but cases do occur. Clinical trials and post-marketing reports suggest:
Although uncommon, the potential seriousness means both patients and providers should stay alert.
Mild hyponatremia may cause vague symptoms. As levels drop further, you may notice more pronounced issues. Watch for:
• Mild symptoms
– Nausea or loss of appetite
– Headache
– Confusion or difficulty concentrating
• Moderate to severe symptoms
– Muscle cramps or spasms
– Weakness or fatigue
– Dizziness, unsteadiness, increased fall risk
– Seizures or loss of consciousness (in severe cases)
If you’re an older woman taking Cymbalta and experience new or worsening symptoms, especially dizziness or confusion, consider checking your sodium level.
Proactive measures can help reduce your risk of low sodium while on Cymbalta:
If you feel odd symptoms while taking Cymbalta, follow these steps:
When low sodium is confirmed, treatment depends on severity:
Your doctor will tailor the approach based on how low the sodium is and how quickly it dropped.
For many older women, Cymbalta provides relief from depression, anxiety, and chronic pain. Low sodium is rare—and when caught early, usually manageable. To strike the right balance:
Always treat potential hyponatremia seriously. Contact your healthcare provider right away if you experience:
These could signal dangerously low sodium requiring immediate attention.
Take-Home Points
Remember: While hyponatremia with Cymbalta is uncommon, it can be serious. If you have any concerning symptoms—or if you’re unsure—speak to a doctor right away. Your health and safety come first.
(References)
* Kulkarni M. Duloxetine induced hyponatremia. Indian J Nephrol. 2015 Jul-Aug;25(4):259. doi: 10.4103/0971-4065.151352. PMID: 26199483; PMCID: PMC4495486.
* Viramontes TS, Truong H, Linnebur SA. Antidepressant-Induced Hyponatremia in Older Adults. Consult Pharm. 2016 Mar;31(3):139-50. doi: 10.4140/TCP.n.2016.139. PMID: 26975593.
* Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, Torp-Pedersen C, Holm EA. Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016 May 18;6(5):e011200. doi: 10.1136/bmjopen-2016-011200. Epub 2016 May 18. PMID: 27194321; PMCID: PMC4874104.
* Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG, Li L, McArthur E, Weir MA, Garg AX. Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults. Am J Kidney Dis. 2017 Jan;69(1):87-96. doi: 10.1053/j.ajkd.2016.08.020. Epub 2016 Oct 20. PMID: 27773479.
* Woroń J, Siwek M, Gorostowicz A. Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders. Psychiatr Pol. 2019 Oct 30;53(5):977-995. doi: 10.12740/PP/OnlineFirst/96286. Epub 2019 Oct 30. PMID: 31955180.
* Şahan E, Parlakkaya Yıldız FB. Duloxetine Induced Hyponatremia. Turk Psikiyatri Derg. 2019 Winter;30(4):287-289. PMID: 32594491.
* Baig MU, Madden K, Moody K. Hyponatremia with Antidepressant: A Rare Side Effect from Duloxetine in a Child with Acute Leukemia. J Palliat Med. 2022 Dec;25(12):1884-1887. doi: 10.1089/jpm.2021.0526. Epub 2022 May 10. PMID: 35537479.
* Siwek M, Woroń J, Wrzosek A, Gupało J, Chrobak AA. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. Front Pharmacol. 2023;14:1271776. doi: 10.3389/fphar.2023.1271776. Epub 2023 Sep 27. PMID: 37829299; PMCID: PMC10565488.
* Kim S, Jo CH, Kim GH. Duloxetine-Induced Antidiuresis in Rats with Lithium-Induced Nephrogenic Diabetes Insipidus. Life (Basel). 2024 Aug 15;14(8). doi: 10.3390/life14081012. Epub 2024 Aug 15. PMID: 39202754; PMCID: PMC11355186.
* Mo H, Channa Y, Ferrara TM, Waxse BJ, Schlueter DJ, Tran TC, Awan AH, Goleva SB, Williams A, Babbar A, Stubblefield O, Keaton JM, Larson EA, Wilke RA, Denny JC. Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research Program. Clin Pharmacol Ther. 2025 Feb;117(2):534-543. doi: 10.1002/cpt.3484. Epub 2024 Nov 14. PMID: 39540435; PMCID: PMC11739749.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.